VP Global Market Access

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.

See Yourself at Telix

The Vice President of Global Market Access will be responsible for developing and executing strategies that ensure the successful global commercialization of Telix’s products. The role requires significant expertise in market access, reimbursement, and health economics, as well as a deep understanding of the regulatory landscape for nuclear medical products. The Vice President of Global Market Access will work closely with the executive leadership team, regional market access, commercial, medical affairs, regulatory affairs, and other cross-functional teams to drive successful product launches and maximize product revenue and patient access.

Key Accountabilities

• Develop and implement global market access strategies: Work with cross-functional teams to develop and execute strategies to secure optimal reimbursement for Telix’s products worldwide. Monitor and evaluate trends in healthcare policy, market access, and reimbursement environments to proactively identify opportunities and risks.
• Monitor and anticipate the evolving market access, institutional customer, and competitive landscape and advocating Telix’s position with respect to Market Access strategy
• Contribute to the globalization of our therapeutics to populations across new and emerging markets
• Define of the pricing, tendering, contracting and life-cycle strategies in close alignment with global colleagues. Manage pricing and market access strategies: Develop pricing and market access strategies with the Regional MAx teams to maximize revenue and patient access, considering the competitive landscape, regulatory environment, and local market factors.
• Lead health economics and outcomes research: Oversee the development of health economic models, clinical and economic value dossiers, and other evidence-based materials to support successful market access and reimbursement decisions. Develop and execute HEOR studies to generate additional evidence and support product value proposition.
• Utilize in depth knowledge of fundamental principles underpinning pharmaceutical industry pricing and access at the different phases of the product lifecycle to make recommendations to business on the selection of appropriate approaches.
• Inform price-setting through pricing research using relevant analytical approaches (game-theory, behavioral economic insights), pricing research methods (Conjoint, Probabilistic, Van Westendorp, etc.)
• Determine optimal Value-Based or Market Based pricing strategies through the application of price setting methodologies, product label and internal product positioning
• Utilize in depth knowledge of innovative pricing models and managed entry schemes to address payer needs
• Set optimal pricing and contracting strategy per market segments in strong collaboration with global market access and local pricing/access teams
• Develop the Global Pricing Policy and associated pricing story
• Establish and maintain relationships with key stakeholders: Develop and maintain relationships with key opinion leaders, reimbursement authorities, and other external stakeholders to ensure successful product launches and ongoing market access.
• Provide input into clinical development plans: Provide input into clinical development plans to ensure that they are aligned with market access and reimbursement requirements.
• Drive cross-functional collaboration: Work closely with cross-functional teams, including commercial, medical affairs, regulatory affairs, and others, to ensure alignment and successful execution of market access strategies.